Dynavax Research Development from 2010 to 2024

DVAX Stock  USD 12.42  0.06  0.49%   
Dynavax Technologies Research Development yearly trend continues to be fairly stable with very little volatility. Research Development will likely drop to about 51.9 M in 2024. During the period from 2010 to 2024, Dynavax Technologies Research Development regression line of annual values had r-squared of  0.000085 and arithmetic mean of  55,473,328. View All Fundamentals
 
Research Development  
First Reported
2001-12-31
Previous Quarter
14.9 M
Current Value
14.4 M
Quarterly Volatility
5.4 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Dynavax Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dynavax Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.7 M, Interest Expense of 4 M or Other Operating Expenses of 282.8 M, as well as many indicators such as Price To Sales Ratio of 7.36, Dividend Yield of 0.0 or PTB Ratio of 4.48. Dynavax financial statements analysis is a perfect complement when working with Dynavax Technologies Valuation or Volatility modules.
  
Check out the analysis of Dynavax Technologies Correlation against competitors.
For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.

Latest Dynavax Technologies' Research Development Growth Pattern

Below is the plot of the Research Development of Dynavax Technologies over the last few years. It is Dynavax Technologies' Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dynavax Technologies' overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Very volatile
   Research Development   
       Timeline  

Dynavax Research Development Regression Statistics

Arithmetic Mean55,473,328
Geometric Mean49,270,908
Coefficient Of Variation39.90
Mean Deviation16,726,138
Median51,887,916
Standard Deviation22,132,061
Sample Variance489.8T
Range78.7M
R-Value0.01
Mean Square Error527.5T
R-Squared0.000085
Significance0.97
Slope45,526
Total Sum of Squares6857.6T

Dynavax Research Development History

202451.9 M
202354.9 M
202246.6 M
202132.2 M
202028.6 M
201962.3 M
201875 M

About Dynavax Technologies Financial Statements

Dynavax Technologies investors use historical fundamental indicators, such as Dynavax Technologies' Research Development, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dynavax Technologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development54.9 M51.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Dynavax Stock Analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.